Bolt BiotherapeuticsBOLT
13F holders, Q3 2024 (September 30)32holders −5
1new positions
6sold out
1famous investor
$0.65avg. 13F price*
At the end of Q3 2024, 32 institutions reported holding Bolt Biotherapeutics Inc. (BOLT) in their 13F filings, down 5 from Q2 2024. 1 opened new positions and 6 sold out. The largest holders were Tang Capital Management LLC ($2.5M), Vivo Capital, LLC ($2.3M) and Sofinnova Investments, Inc. ($1.8M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Bolt Biotherapeutics Inc.
- CUSIP
- 097702104
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $26K |
| Exits | 6 | $2.3M |
All 13F filers, Q2 2024 → Q3 2024: 283,692 shares bought and 4,130,135 shares sold, net −3,846,443 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| Tang Capital Management LLC | 0.18% | No change | 3,812,773 | $2.5M |
| Vivo Capital, LLC | 0.19% | No change | 3,521,291 | $2.3M |
| Sofinnova Investments, Inc. | 0.15% | No change | 2,754,437 | $1.8M |
| Pivotal bioVenture Partners Investment Advisor LLC | 0.73% | No change | 1,891,467 | $1.2M |
| Nan Fung Group Holdings Ltd | 0.65% | No change | 1,166,952 | $756K |
| Vanguard Group Inc. | 0.00% | No change | 1,067,405 | $692K |
| Samsara Biocapital, LLC | 0.13% | No change | 1,049,153 | $680K |
| Board of Trustees of The Leland Stanford Junior University | 0.04% | No change | 719,546 | $466K |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 500,000 | $324K |
| Newtyn Management, LLC | 0.05% | Reduce -65.6% | 468,910 | $304K |
| Geode Capital Management, LLC | 0.00% | Reduce -5.0% | 352,426 | $228K |
| Renaissance Technologies | 0.00% | Add +6.3% | 294,039 | $191K |
| BlackRock, Inc. | 0.00% | — | 269,608 | $175K |
| ADAR1 Capital Management, LLC | 0.03% | Add +31.7% | 244,966 | $159K |
| Susquehanna International Group, LLP | 0.00% | Add +560.1% | 147,926 | $96K |
| FMR LLC | 0.00% | Add +33.2% | 115,386 | $75K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -29.3% | 60,200 | $39K |
| Prudential Financial Inc. | 0.00% | Add +8.8% | 59,200 | $38K |
| State Street Corp. | 0.00% | No change | 47,437 | $31K |
| Northern Trust Corp. | 0.00% | No change | 40,895 | $27K |
| Mariner, LLC | 0.00% | New | 40,535 | $26K |
| UBS Group AG | 0.00% | Reduce -27.7% | 35,297 | $23K |
| Jane Street Group, LLC | 0.00% | Reduce -32.3% | 28,102 | $18K |
| Two Sigma Securities, LLC | 0.00% | Reduce -52.7% | 25,509 | $17K |
| Morgan Stanley | 0.00% | Reduce -30.4% | 23,449 | $15K |
| Assenagon Asset Management S.A. | 0.00% | Reduce -39.7% | 20,785 | $13K |
| Osaic Holdings, Inc. | 0.00% | Add +15.7% | 17,355 | $11K |
| Bank of America Corp. | 0.00% | Add +855.4% | 6,000 | $4K |
| JPMorgan Chase & Co. | 0.00% | Add +8.8% | 914 | $592 |
| Tower Research Capital LLC (TRC) | 0.00% | No change | 184 | $119 |
| Barclays PLC | 0.00% | No change | 139 | $90 |
| Salem Investment Counselors Inc. | 0.00% | No change | 40 | $26 |
"% of holder's portfolio" is BOLT's weight in each manager's 13F, not the share of Bolt Biotherapeutics Inc. the manager owns.